-

PENSKE INVESTIGATION ALERT: Kaskela Law Firm is Investigating Penske Automotive Group, Inc. (PAG) and Encourages PAG Stockholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it has launched an investigation on behalf of Penske Automotive Group, Inc. (NYSE: PAG) (“Penske Automotive”) stockholders.

On July 22, 2026, Penske Automotive reported that it had received a proposal from Penske Corp. and Mitsui & Co., Ltd., who collectively own over 72% of the company’s stock, to acquire the remaining shares of Penske Automotive stock that they do not currently own for $210.00 per share in cash.

The investigation seeks to determine whether the proposed $210.00 per share in cash represents sufficient monetary consideration for Penske Automotive shares, or if the offer undervalues the company’s shares and potentially shortchanges PAG investors.

Penske Automotive shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at abell@kaskelalaw.com for additional information about their legal rights and options. Investors may also request additional information about this investigation and their options by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/penske/

ABOUT KASKELA LAW:

Kaskela Law exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis (i.e., the firm’s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:PAG

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

SHAREHOLDER ALERT: Kaskela Law is Investigating the Proposed Buyout of Distribution Solutions Group (DSGR) Shareholders to Determine Whether the Proposed $35.00 Per Share Offer Shortchanges Investors

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the proposed Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG”) shareholder buyout to determine whether DSG shareholders may be able to obtain a higher price for their shares.Click here for additional information: https://kaskelalaw.com/case/dsg/On July 16, 2026, DSG announced that it had agreed to be acquired by private equity firm LKCM Headwater Investments (“LKCM Headwater”) at a price of $35.00 per share in ca...

SHAREHOLDER ALERT: Kaskela Law is Investigating the Proposed Buyout of Utz Brands (UTZ) Shareholders to Determine Whether the Proposed $14.25 Per Share Offer Shortchanges Investors

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the proposed Utz Brands, Inc. (NYSE: UTZ) (“Utz”) shareholder buyout to determine whether Utz shareholders may be able to obtain a higher price for their shares. Click here for additional information: https://kaskelalaw.com/case/utz-buyout/ On July 21, 2026, Utz announced that it had agreed to be acquired by European snack manufacturer Intersnack Group GmbH & Co. KG (“Intersnack”) at a price of $14.25 per share in c...

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Amneal or the company’s officers and/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional infor...
Back to Newsroom